Company news
Inter Pharma Public Company Limited (SET:IP) news
Inter Pharma Public Company Limited news releases on 6ix. Latest, Aug 16, 2022: Inter Pharma : New shares of IP to be traded on August 18, 2022
Press releases & updates
Inter Pharma : New shares of IP to be traded on August 18, 2022
August 16, 2022
Inter Pharma Public : Notification on Change of Directors and Authorization of Directors
August 10, 2022
Inter Pharma Public : Right Adjustment of IP-W1 (Edited)
August 10, 2022
Inter Pharma Public : Report on the results of sale of common shares offered to private placement (F53-5)
August 10, 2022
Inter Pharma Public : Right Adjustment of IP-W1
August 9, 2022
Inter Pharma Public : Notification on the Offering Date of Newly-issued Ordinary Shares to Private Placement and Calculation of the Offering Price
August 9, 2022
Inter Pharma Public : Publication of the Minute of the Extraordinary General Meeting of Shareholders No. 1/2022 on the Company's Website
August 2, 2022
Inter Pharma Public : Report on the Utilization of Capital Increased as at June 30th, 2022
July 27, 2022
Inter Pharma Public : Notification on the registration of the increase of the Company's registered capital
July 22, 2022
Inter Pharma Public : Notification on the registration of the reduction of the Company's registered capital
July 21, 2022
Inter Pharma Public : Resolution of the Extraordinary General Meeting of Shareholders No. 1/2022
July 20, 2022
Inter Pharma Public : Publication of the Invitation to the Extraordinary General Meeting of Shareholders No. 1/2002 on the Company's Website
July 4, 2022
Inter Pharma Public : Postponement of the Extraordinary General Meeting of Shareholders No. 1/2022
June 10, 2022
Inter Pharma Public : Notification the exercise of IP-W1 No. 3
June 6, 2022
Inter Pharma Public : Schedule for the Extraordinary General Meeting of Shareholders No. 1/2022, the capital reduction and increase of registered capital, the offering of new shares to PP and Increasing Capital under General Mandate (edit)
May 19, 2022
Inter Pharma Public : Report on the results of the Exercise of IP-W1 (F53-5)
April 1, 2022
Inter Pharma Public : Board Resolution of Omitted Dividend Payment, Extension of Increasing Capital under General Mandate, Changing the Objectives of Using the IPOs Proceed and Scheduling of 2022 Annual General Meeting of Shareholders (Revised)
March 9, 2022
Inter Pharma Public : Notification the exercise of IP-W1
March 7, 2022